ClinicalTrials.gov
ClinicalTrials.gov Menu

Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00284388
Recruitment Status : Withdrawn
First Posted : January 31, 2006
Last Update Posted : February 16, 2009
Sponsor:
Information provided by:
University Hospital, Ghent

Brief Summary:

Development of a non-invasive method for the determination of the position of optimal muscle length in the different muscles of the shoulder.

Analysis of the adaptation of the muscle to a new optimal length in patients with a shoulder prosthesis.


Condition or disease Intervention/treatment Phase
Shoulder Prosthesis Procedure: Simultaneous controlled power measurement Procedure: Surface EMG measurement Not Applicable

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Incorporation of Muscle Qualities in Biomechanical Models of the Upper Limbs



Primary Outcome Measures :
  1. Measurement of the optimal length of the muscles of the shoulder


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Shoulder prosthesis

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00284388


Sponsors and Collaborators
University Hospital, Ghent
Investigators
Principal Investigator: Rene Verdonk, MD, PhD University Hospital, Ghent

Additional Information:
Responsible Party: René Verdonk, University Hospital Ghent
ClinicalTrials.gov Identifier: NCT00284388     History of Changes
Other Study ID Numbers: 2004/056
First Posted: January 31, 2006    Key Record Dates
Last Update Posted: February 16, 2009
Last Verified: February 2009